KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Dr Tolulope Adewole speaks to ecancer about how the Nigeria Sovereign Investment Authority (NSIA) and BIO Ventures for Global Health (BVGH) are working in partnership to improve patient outcomes.
He outlines some of the important work the NSIA and BVGH are doing to build capacity and improve access to quality cancer care for patients.
Dr Adewole explains some of the challenges and opportunities that come with working to improve patient outcomes in Nigeria. He also explains the role of public-private partnerships in improving cancer care.
He concludes by emphasising the importance of working together in collaboration to address improvements for patient outcomes in Nigeria.
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
OncoAlert Round Up for August 4th - 10th, 2023
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers
Cancer Care in Older Adults and Special Population
Advancing breast cancer diagnosis in the developing world